Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.
作者信息
Navascués Rafael A, Gómez Ernesto, Rodriguez Minerva, Laures Ana S, Baltar Jose, Grande Jaime A
出版信息
Nephron. 2002 May;91(1):173-4. doi: 10.1159/000057624.
PMID:12021539
Abstract
摘要
相似文献
1
Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.
Nephron. 2002 May;91(1):173-4. doi: 10.1159/000057624.
2
Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout.
Transplantation. 1997 Oct 15;64(7):1087-8. doi: 10.1097/00007890-199710150-00027.
3
Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Transplant Proc. 1999 Nov;31(7):3007-8. doi: 10.1016/s0041-1345(99)00644-2.
4
Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients.
Transplant Proc. 2000 Feb;32(1A Suppl):6S-8S. doi: 10.1016/s0041-1345(00)00808-3.
5
Mycophenolate mofetil in cyclosporine-associated nephrotoxicity.
Transplant Proc. 1998 Sep;30(6):2825-7. doi: 10.1016/s0041-1345(98)00827-6.
6
Use of mycophenolate mofetil in renal transplant patients with cyclosporin toxicity.
Transplant Proc. 1999 Dec;31(8):3294. doi: 10.1016/s0041-1345(99)00730-7.
7
Influence of serum uric acid levels in response to the conversion from mycophenolate mofetil to mizoribine in kidney transplant recipients.
Transplant Proc. 2013 Jan-Feb;45(1):190-3. doi: 10.1016/j.transproceed.2012.10.030.
8
Use of mycophenolate mofetil in patients with chronic cyclosporine nephrotoxicity.
Transplant Proc. 1998 Jun;30(4):1194. doi: 10.1016/s0041-1345(98)00205-x.
9
Contribution of mycophenolate mofetil after withdrawal of cyclosporine to toxicity in kidney transplantation.
Transplant Proc. 1998 Sep;30(6):2809-10. doi: 10.1016/s0041-1345(98)00819-7.
10
Tolerance of mycophenolate mofetil is dependent on kidney function.
Transplant Proc. 1998 Aug;30(5):2228. doi: 10.1016/s0041-1345(98)00599-5.
引用本文的文献
1
Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial.
BMC Cancer. 2020 Mar 30;20(1):268. doi: 10.1186/s12885-020-06751-2.
2
Effects of hyperuricemia on renal function of renal transplant recipients: a systematic review and meta-analysis of cohort studies.
PLoS One. 2012;7(6):e39457. doi: 10.1371/journal.pone.0039457. Epub 2012 Jun 22.
3
Gout and organ transplantation.
Curr Rheumatol Rep. 2012 Apr;14(2):165-72. doi: 10.1007/s11926-012-0235-9.
Zotero 插件